Co-administration of probenecid, an inhibitor of a cMOAT/MRP-like plasma membrane ATPase, greatly enhanced the efficacy of a new 10-deazaaminopterin against human solid tumors in vivo. (Q54035995)
Jump to navigation
Jump to search
scientific article published in September 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Co-administration of probenecid, an inhibitor of a cMOAT/MRP-like plasma membrane ATPase, greatly enhanced the efficacy of a new 10-deazaaminopterin against human solid tumors in vivo. |
scientific article published in September 2000 |
Statements
Co-administration of probenecid, an inhibitor of a cMOAT/MRP-like plasma membrane ATPase, greatly enhanced the efficacy of a new 10-deazaaminopterin against human solid tumors in vivo (English)
F M Sirotnak
H G Wendel
W G Bornmann
W P Tong
V A Miller
1 September 2000